. In the present study, we attempted first to confirm whether the denatured albumins generally increase in conditions of oxidative stress and second to characterize the degradative process of the denatured albumin using primary cultured rat liver endothelial cells. We used five models of oxidative stress, including endotoxicosis, ischemic heart disease, diabetes, acute inflammation, and aging, and found that serum concentrations of D3 albumin correlate with the serum levels of thiobarbituric acid-reactive substance (R ϭ 0.87), whereas the concentrations of D2 albumin are 0.52. Ligand blot analysis showed that the D3 albumin binds to gp18 and gp30, which are known endothelial scavenger receptors for chemically denatured albumin. Primary cultured rat liver endothelial cells degraded the FITC-D3 albumin, and the degradation rate decreased to ϳ60% of control levels in response to anti-gp18 and anti-gp30 antibodies, respectively. An equimolar mixture of these antibodies produced an additive inhibitory effect on both uptake and degradation, resulting in levels ϳ20% those of the control. Furthermore, filipin and digitonin, inhibitors of the caveolae-related endocytic pathway, reduced the FITC-D3 albumin uptake and degradation to Ͻ20%. Laserscanning confocal microscopic observation supported these data regarding the uptake and degradation of D3 albumin. These results indicate that conformationally denatured D3 albumin occurs generally under oxidative stress and is degraded primarily via gp18-and gp30-mediated and caveolae-related endocytosis in liver endothelial cells. serum albumin; denaturation; scavenger receptor; caveolae EARLY IN VIVO STUDIES with radioisotope-labeled albumin have revealed the constant plasma half-life to be 2-2.5 days in rats (41). Conformationally altered albumin, however, is well known to show an extremely short half-life in circulating blood (31). Such changes in the degradation rate of serum albumin as well as of other serum proteins seem to occur under an individual degradative process, but the underlying mechanisms have not been clarified on a molecular basis. On the other hand, experimental data show that free radical species are responsible for conformational changes and fragmentation of protein molecules (12). Again, the elimination mechanisms for these denatured proteins from circulating blood and their degradative processes in the body remain unclear.
Recently, several types of receptors that bind to modified albumin have been reported. These receptors include the following: gp18 and gp30, scavenger receptors for chemically modified albumin (47, 51) ; LOX-1, a lectin-like oxidized low-density lipoprotein receptor 1 (23) ; SREC, a scavenger receptor expressed by endothelial cells for modified LDL (1); FEEL-1 and FEEL-2 (also known as stabilin-1 or stabilin-2), endocytic receptors for advanced glycation end product (AGE) (20, 55) ; SR-A, a scavenger receptor class A for modified LDL (27, 28) ; RAGE, a receptor for AGE (33) ; OST-48, a 48-kDa member of the oligosaccharyltransferase complex; 80K-H, an 80-to 87-kDa protein substrate for protein kinase C (29) ; and unnamed 15-, 35-, and 85-kDa proteins (38, 39, 44) . Among these binding proteins, gp18 and gp30 were originally reported by Schnitzer and colleagues (47, 51) , who characterized the binding properties between the membrane protein fraction from endothelial cells and chemically modified albumins such as maleylated and formylated albumin. They also showed that gp18-and gp30-mediated endocytosis is one route for the degradation of chemically denatured albumin.
In addition to the cell surface receptors that recognize the modified albumin, intracellular events leading to lysosomal degradation have also been investigated. Caveolin is an intracellular protein that participates in the transportation of molecules inside cells. Caveolin-coated plasmalemmal vesicles (caveolae) have been found to transport many molecules, including lipids, acylated proteins, membrane receptors and transporters, structural molecules, and so forth (6, 45) . Chemically modified albumins such as maleylated and formylated albumins also have been reported to transport by the caveolaemediated endocytosis leading to the lysosome (46, 50) .
Although the findings summarized above are thought to provide important evidence regarding the degradative mechanisms of denatured albumin in the body, all of these results were obtained using chemically, that is, artificially, modified albumins. As such, it remains unclear whether the denatured albumin generated in the body behaves in the same way as the chemically modified albumins. We recently isolated and characterized denatured albumin (D2 and D3 albumin) from rats with endotoxicosis (4) . In the present study, we first attempted to clarify whether the physiologically denatured albumins (D2 and D3 albumin) are generally produced by oxidative stress in the body. Next, using the physiologically denatured albumin and primary cultured liver endothelial cells (LECs), we attempted to clarify 1) whether physiologically denatured albumin binds to gp18 and gp30 cell surface receptors that have been confirmed using chemically modified albumins, 2) whether physiologically denatured albumin reaches the lyso-some via caveolae-mediated endocytosis after attaching to cell surface receptors gp18 and gp30, and 3) the relative contribution of gp18-and gp30-mediated endocytosis to the breakdown of physiologically denatured albumin in endothelial cells.
MATERIALS AND METHODS

Materials
N
-nitro-L-arginine methyl ester (L-NAME), streptozotocin (STZ), fluorescein isothiocyanate (FITC), lipopolysaccharide (LPS; serotype type L-4130), fluoresceinamin, filipin, phenyl arsine oxide (PAO), and fucoidan were purchased from Sigma Chemical (St. Louis, MO). Blue Sepharose CL-6B, Sephacryl S-300, DEAE Sephadex A-50, Cy3 fluorescent dye, and cyanogen bromide-activated Sepharose CL4B were obtained from Amersham Biosciences (Piscataway, NJ). Alexa Fluor 488 and LysoTracker Red DND-99 were purchased from Molecular Probes (Eugene, OR). FITC-labeled anti-rabbit IgG (goat) was obtained from Vector Laboratories (Burlingame, CA). 2,4,6-trinitrobenzenesulfonic acid (TNBS) was purchased from Kanto Kagaku (Tokyo, Japan). Sodium dextran sulfate was obtained from MP Biomedicals (Aurora, OH). Concanavalin A and collagenase were purchased from Wako Pure Chemical Industries (Osaka, Japan). All other chemicals used were of analytical grade.
Experiment 1: Induction of Oxidative Stress and Determination of Denatured Albumin
Animals. Male Wistar rats (6 wk and 6 mo old) were purchased from Japan Laboratory Animals (Tokyo, Japan). The rats were housed in a light-cycle room lit from 8 AM to 8 PM at a temperature of 22°C, and the animals were allowed free access to commercial chow and water for 1 wk.
Young rats (6 wk old) were orally administered NO synthase inhibitor L-NAME in drinking water (1 mg/ml; Ref. 25) to induce ischemic heart disease (IHD). Their daily intake of L-NAME was from 25 to 40 mg/day. Diabetes was induced by administering an intraperitoneal injection of STZ (65 mg/kg body wt; Ref. 40) . The plasma levels of glucose were 468 Ϯ 29 mg/dl at 7 days after the STZ injection. Acute inflammation was induced by a subcutaneous injection of turpentine oil (5 ml/kg body wt; Ref. 52). Endotoxicosis was induced by administering an intraperitoneal injection of LPS (5 mg/kg body wt; Ref. 4). These rats with induced IHD, diabetes, acute inflammation, and endotoxicosis were killed by performing thoracic incisions after withdrawal of the blood samples while the rats were under Nembutal anesthesia at 1.5, 2, 7, and 10 days after the respective operations. Six-month-old rats were killed without having undergone any operation for comparison with the age-related changes with 6-wk-old rats. Plasma thiobarbituric acid-reactive substance (TBARS) was determined fluorometrically using the method of Yagi (59) .
All procedures concerning the animal experiments were performed according to the guidelines established by the Institutional Animal Care and Use Committee of Meiji University.
Preparation of native, chemically modified, and physiologically denatured albumin. Rat serum albumin was purified according to a previously described method (4). Briefly, after being dialyzed against 50 mM Tris ⅐ HCl buffer (pH 7.0) containing 50 mM sodium chloride, rat plasma was applied to a Blue Sepharose CL-6B and Sephacryl S-300 column. Serum albumin eluted in the major peak of the gel chromatography was used as "native albumin" (␣-helix content was Ͼ67%; Ref. 9) . The purity of the albumin was confirmed by performing SDS-PAGE.
Two kinds of chemically modified albumins, formylated albumin (F-Alb) and maleylated albumin (M-Alb), were prepared. 1) Formylation of albumin was performed according to a previously described method (21) . The purified native albumin (8 ml of 4 mg/ml native albumin) was mixed with formaldehyde solution (final concentration 20% vol/vol) and incubated for 1 h at 37°C and then dialyzed against phosphate-buffered saline (PBS). 2) Maleylation of albumin was performed according to a previously described method (7). After being dialyzed against 0.1 M sodium pyrophosphate buffer (pH 9.0), the purified native albumin (5 ml of 4 mg/ml) was mixed with 0.5 ml of 1 M maleic anhydride in 1,4-dioxane at pH 9.0 and left for 5 min at 2°C and then dialyzed against PBS. Free amino groups of each albumin were determined using the TNBS method (17) . The formylation and maleylation of the amino groups of the albumin molecule occurred at 37.7 and 95.5% efficiency, respectively. The ␣-helix contents for F-Alb and M-Alb were 32.4 and 31.4%, respectively. D2 and D3 albumins were isolated according to a previously described method (4) . The Blue Sepharose CL-6B, Sephacryl S-300, and DEAE Sephadex A-50 columns were used to isolate these albumins from rats that had received five kinds of oxidative stress (IHD, diabetes, acute inflammation, endotoxicosis, and aging). The conformational nature of these albumins was confirmed using CD and proteolytic susceptibility analysis. Protein concentrations were determined according to the method of Bradford.
Preparation of antibodies. Japanese White male rabbits were immunized with native albumin or M-Alb. Freund's complete adjuvant was used for the first immunization, and incomplete adjuvant was used for the subsequent immunizations.
The IgG against the specific epitopes of M-Alb was prepared using a previously described method (4) . Briefly, anti-M-Alb IgG was mixed with an excessive amount of native albumin and left for 1 day. IgG native albumin complex was removed by performing centrifugation at 12,000 g for 20 min. The supernatant was then applied to a Blue Sepharose CL-6B column to remove free native albumin. The protein solution passing through the column was used as specific M-Alb IgG. The binding specificities of the specific M-Alb IgG against whole plasma proteins were confirmed using Western blot analysis and peptide mass fingerprinting (4) .
Quantification of total and denatured albumins. Plasma total albumin (native ϩ denatured forms) and denatured (D2 and D3) albumins were quantified according to a previously described method (4). Briefly, rat plasma was subjected to SDS-PAGE (for total albumin) or native PAGE (for denatured albumins). The proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane at 50 V for 2 h. Total albumin was quantified using anti-native albumin antiserum (first antibody), and denatured albumins were quantified using the purified IgG against the specific epitopes of M-Alb (first antibody). The fluorescence intensity of FITC-labeled anti-rabbit goat IgG (secondary antibody) was determined using a FluorImager 595 (Amersham Biosciences, Piscataway, NJ).
CD measurements. CD measurements were performed according to the method of Khan et al. (26) . All measurements were performed at 25°C using a spectropolarimeter (J-805; Jasco, Tokyo, Japan). Far UV CD spectra (200 -250 nm) were obtained using a 0.1-cm path length cell at a protein concentration of 1.8 M in sodium phosphate buffer (pH 7.0). The results are expressed as the mean residue ellipticity (MRE). The helical content of the proteins was calculated using the method of Chen et al. (11) .
Proteolytic susceptibility. The lysosomal fraction from rat liver was purified according to the method of Ohshita et al. (37) . The proteolytic susceptibility of conformationally different albumins was evaluated according to a previously described method (36) . These albumins were dialyzed against ultrapure water. Each protein (34 l of 0.4 mg/ml) was digested with 34 l of lysosomal enzymes (1.0 mg/ml) for 2 h at 37°C, pH 5.0. The proteolytic reaction was terminated by mixing with 32 l of denaturation buffer (3% SDS, 1.2% 2-mercaptoethanol, 2 M urea, 3 mM EDTA, and 0.17 M Tris ⅐ HCl, pH 7.8) and boiling for 10 min, and then the mixture was subjected to SDS-PAGE, followed by Western blot analysis. The fluorescence intensities of the original bands were determined using the FluorImager 595.
Experiment 2: Albumin Uptake and Degradation in Primary Cultured Liver Endothelial Cells
Protein labeling with fluorescent dyes. FITC, Alexa 488, and Cy3 fluorescent dyes were used for protein labeling. Labeling procedures were performed according to the manufacturer's instructions. Proteins used in this part of the experiments were prepared as follows. Native albumin was purified from nontreated rats in the manner described in Preparation of native, chemically modified, physiologically denatured (D2 and D3) albumin. D3 albumin was isolated from rats with endotoxicosis. Anti-gp18 and anti-gp30 antibodies were prepared in the manner described in Isolation and immunization of gp18 and gp30. Our preliminary experiments indicated that labeling with fluorescent dyes FITC and Alexa 488 had no serious influence on the conformational nature of native albumin in terms of the ␣-helical content.
Preparation of rat liver membrane proteins. The membrane protein fraction from rat liver was prepared using the differential centrifugation method (39, 56) . Briefly, rat liver was perfused from the hepatic portal vein using 100 ml of PBS and homogenized in 200 ml of 150 mM NaCl dissolved in buffer A (0.1 mM EDTA, 0.2% 2-mercaptoethanol, and 50 mM Tris ⅐ HCl, pH 8.0). After centrifugation at 105,000 g for 1 h at 4°C, the pellet was resuspended in 200 ml of buffer B (50 mM NaCl and 40 mM n-octyl-␤-D-glucopyranoside dissolved in buffer A). The resuspended solution was centrifuged at 105,000 g for 1 h at 4°C, and the supernatant was collected as membrane proteins.
Isolation and immunization of gp18 and gp30. An M-Alb affinity column was prepared according to a previously described method (28, 48) . Briefly, the Sepharose 4B beads (1.5 g) were incubated at 4°C for 24 h with 45 mg of M-Alb in 50 ml of coupling buffer (0.5 M NaCl and 0.1 M NaHCO3, pH 8.3). The coupling efficiency was 1.5 mg of M-Alb/ml of gel. A membrane fraction from rat liver (2 mg of protein) was applied to the M-Alb affinity column (1 ϫ 5 cm), and proteins were eluted from the column using the stepwise concentration of NaCl (50, 250, and 1,000 mM). These procedures were performed according to a previously described method (2, 48, 56) . After confirming the positions of gp18 and gp30 on the PVDF membrane using ligand blot analysis (see below), gel pieces containing gp18 or gp30 were excised from the PAGE gels, and each protein was eluted using an electroelution apparatus (422 Electroeluter; Bio-Rad). Anti-gp18 and antigp30 antibody were prepared in the manner described in Preparation of antibodies. The binding specificities of anti-gp18 and anti-gp30 IgG against total liver membrane proteins were confirmed by SDS-PAGE followed by Western blot analysis.
Ligand blot. The ligand blot was performed according to the method of Schnitzer et al. (51) and our preliminary experiments using both FITC-labeled F-Alb and M-Alb. Membrane proteins (500 g) were separated by performing SDS-PAGE and transferred onto PVDF membrane filters at 50 V for 30 min. After being washed with PBS containing 0.1% Tween 20 (vol/vol), the filter membranes were incubated with FITC-labeled D3 albumin (30 g/ml) or FITC-labeled native albumin (0.03 or 3 mg/ml) for 1 h. For competition analysis with another protein, the FITC-labeled D3 albumin was mixed with unlabeled competitors (10-fold molar excess of protein competitor or 1 mg/ml of polyanionic molecules and concanavalin A; Ref. 47) . Fluorescence scavenging, quenching, and insolubilization caused by the addition of nonlabeled albumins were confirmed to be negligible in our preliminary experiments.
Isolation and culture of LECs. LECs were separated from hepatocytes by differential centrifugation (60) . Aliquots (1.3 ml) of the LEC suspensions were seeded in collagen-coated 35-mm dishes (4 ϫ 10 6 cells). These LECs were incubated for 3 h at 37°C in a humidified incubator under 5% CO 2 in air. Each dish was washed twice with medium A (Williams's medium E supplemented with 10% FBS, 100 g/ml streptomycin, 20 mM HEPES, and 100 IU/ml penicillin) to remove nonadherent cells, after which incubation was continued for 2 h at 37°C with medium A excluding FBS. LEC populations in cultured cells were confirmed by confocal microscopic observation after the incorporation of fluoresceinamin-labeled ovalbumin (3 g/ml medium; Refs. 5, 47) . The purity of the isolated LECs was 86 Ϯ 4%.
Binding, uptake, and degradation assay of FITC-labeled albumin. The binding and uptake assay was performed as described previously (35) . The LECs in culture were washed with medium A and refurnished with 1.3 ml of medium A containing the FITC-labeled D3 albumin with or without an excess of unlabeled ligand. After incubation for 2 h at 4°C (for the binding assay) or 37°C (for the uptake assay), the culture medium was taken from each dish. The nonspecific fluorescence was determined in the presence of unlabeled D3 albumin (a 20-fold molar excess). For the competition analysis, FITC-labeled D3 albumin was mixed with an unlabeled competitor (10-fold molar excess) or 1 mg/ml of polyanionic molecules (47) before incubation. To determine the endocytic pathway of D3 albumin, FITC-labeled D3 albumin was used for quantitative analyses, and Alexa 488-labeled D3 albumin was used for confocal microscopic observations. Filipin (5 g/ml) (50) and digitonin (4 M) (43), inhibitors of caveolae-related endocytosis, and PAO (2 M) (3), an inhibitor of clathrin-related endocytosis, were added to the culture medium in both the uptake and degradation assays. These dishes were washed twice using 0.35 ml of PBS, and LECs in each dish were scraped twice using 1.0 ml of homogenate buffer (4.77 g/l HEPES and 85.6 g/l sucrose, pH 7.5). Two milliliters of harvested samples were homogenized using the Polytron (PT1200; Kinematica, Lucerne, Switzerland) and then centrifuged at 8,000 g for 10 min at 4°C. The supernatant was transferred to microplates, the fluorescence intensity was determined using the FluorImager 595, and cellular protein was estimated using the method described above.
To quantify the degradation of FITC-labeled albumin, the intensity of TCA-soluble fluorescence was measured according to the method of Gekle et al. (18) . Briefly, LECs were cultured with FITC-labeled D3 albumin in the manner described in Isolation and culture of LECs. After a 2-h incubation, cells were harvested and homogenized in the manner described above. One milliliter of 10% TCA was added to 1 ml of cellular homogenate and kept in an ice-cold bath for 10 min. After centrifugation at 8,000 g for 10 min, the supernatant was adjusted to pH 7.4 using a 1 M Na 2HPO4 buffer. The fluorescence of the supernatant was determined using the FluorImager 595.
Confocal microscopy. Confocal images were captured according to the method of John et al. (22) . Briefly, glass-bottomed culture dishes (MatTek, Ashland, MA) were coated with collagen using 0.03% collagen in 0.1 N acetic acid. LECs were cultured for 2 h with medium A containing the following fluorescent probes: 1) LysoTracker (50 nM) and Alexa 488-labeled D3 albumin (2 g/ml), 2) Cy3-labeled anti-gp18 IgG (3 g/ml) and Alexa 488-labeled D3 albumin (20 g/ml), and 3) LysoTracker (50 nM) and Alexa 488-labeled D3 albumin (2 g/ml) with unlabeled anti-gp18 and anti-gp30 IgG (50 g/ml each). Confocal images of LECs were captured using a laserscanning confocal microscope (LSM 510; Zeiss, Oberkochen, Germany). Excitation lines of 488 and 568 nm were used to detect Alexa 488 (BP 505-to 550-nm emission) and LysoTracker/Cy3 fluorescence (LP585 emission), respectively. Optical sections were set at Ͻ1 m.
Statistical Analysis
Values are expressed as means Ϯ SE. Statistical significance was evaluated using one-way ANOVA, followed by Fisher's multiplerange test. Differences were considered significant at P Ͻ 0.05.
RESULTS
Plasma Appearance of Denatured Albumins in Oxidative Stress in Vivo
In this study, we first attempted to confirm whether denatured albumins such as those we previously identified in rats with endotoxicosis generally increase in response to other kinds of oxidative stress. For this purpose, we used five kinds of oxidative stress: IHD, diabetes, acute inflammation, endotoxicosis, and aging. As shown in Table 1 , plasma TBARS levels were significantly higher (2.5 to 4.0 fold) in the five models of oxidative stress compared with young control rats, and severe hypoalbuminemia was observed in IHD, acute inflammation, and endotoxicosis. Accordingly, a negative correlation (R ϭ Ϫ0.94) between plasma TBARS levels and plasma concentrations of total albumin was observed (see Fig.  2A ). We next determined the presence of denatured albumins using the purified IgG against the specific epitopes of M-Alb. Two major immunoreactive plasma albumins were detected at the same R f values as those of D2 (0.39) and D3 (0.26) albumin in rats with endotoxicosis on PVDF membrane transferred from native PAGE gels (Fig. 1A) . The ␣-helical content of D2-like and D3-like albumin was 32-33% and Ϫ4 -0%, respectively, and there was no significant difference among the five models. Lysosomal enzymes isolated from rat liver were used to estimate the proteolytic susceptibility of these albumins. The percentage of the original band remaining on PVDF membrane transferred from SDS-PAGE gels at 2 h after incubation with lysosomal enzymes was 54 -61% in D2-like albumin and 31-36% in D3-like albumin. Again, we observed no significant differences in proteolytic susceptibility of these albumins in response to each treatment. On the basis of the results described above, we confirmed that D2 and D3 albumins are generally recognized in the oxidative stress used in this study.
Plasma concentrations of D2 and D3 albumin increased significantly in the five kinds of oxidative stress (Fig. 1, B and C). The increments in D2 and D3 albumin, however, were not necessarily the same when compared under the same oxidative stress. Figure 2 , B and C, shows the correlation between plasma TBARS levels and plasma concentrations of D2 and D3 albumin. A positive correlation (R ϭ 0.87) was observed between plasma levels of TBARS and D3 albumin. Altogether, two kinds of denatured (D2 and D3) albumin are generally recognized, and their plasma concentrations increase in response to the oxidative stress used in this study.
Binding Characteristics of D3 Albumin to Liver Membrane Proteins
To characterize the binding properties of D3 albumin to liver membrane proteins, ligand blot analysis with several competitors was performed. FITC-labeled D3 albumin (30 g/ml each) bound to the 18-and 30-kDa proteins on the PVDF Values are means Ϯ SE of data from three rats. N -nitro-L-arginine methylester (L-NAME), streptozotocin (STZ), turpentine oil, and lipopolysaccharide (LPS) were administered to induce ischemic heart disease (IHD), diabetes, acute inflammation, and endotoxicosis, respectively. Blood samples were obtained at the most severe period in each treatment used in this study: IHD at 10 days, diabetes at 7 days, acute inflammation at 2 days, and endotoxicosis at 1.5 days after the injection. Six-month-old rats were used for aged rats without any treatment. Plasma thiobarbituric acid-reactive substance (TBARS) levels were determined fluorometrically (59), and total albumin was determined using anti-rat albumin antibody. Statistical significance was evaluated using one-way ANOVA followed by Fisher's multiple-range tests. *P Ͻ 0.05, †P Ͻ 0.01, and ‡P Ͻ 0.001 vs. control. Table 1 ). Values are means Ϯ SE of three rats. Statistical significance was evaluated using one-way ANOVA followed by Fisher's multiple range test. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 vs. control.
membrane (Fig. 3A, lane 1) . FITC-labeled chemically modified albumins, M-Alb and F-Alb (30 g/ml each), bound similarly to the 18-and 30-kDa proteins on the PVDF membrane. The same concentration (30 g/ml) of FITC-labeled native albumin showed no detectable bands against liver membrane proteins (Fig. 3A, lane 2) . However, FITC-labeled native albumin bound to 18-, 30-, and 60-kDa proteins at the higher concentration of 3 mg/ml (Fig. 3A, lane 3) . On the basis of the molecular weights and their binding characteristics to several albumins, we judged these 18-and 30-kDa proteins to be gp18 and gp30, respectively, both of which were previously reported by Schnitzer and colleagues (47, 51) . The 60-kDa protein is thought to be gp60, which is known as the receptor for transcytosis of native albumin in endothelial cells (32, 49, 57, 58) . Further binding characteristics of D3 albumin to gp18 and gp30 membrane proteins are shown in Fig. 3 , B and C. A 10-fold excess of unlabeled F-Alb, M-Alb, and D3 albumin significantly reduced the FITC-labeled D3 albumin binding to Ͻ20%. Anti-gp18 IgG, anti-gp30 IgG, and specific M-Alb IgG reduced the binding to Ͻ40%, respectively. Furthermore, polyanionic macromolecules (dextran sulfate, fucoidan), and concanavalin A reduced the binding to Ͻ50%. On the other hand, native albumin and preimmune IgG were not the competitors for FITC-labeled D3 albumin binding. These results indicate that both gp18 and gp30 recognize D3 albumin as well as M-Alb and F-Alb and that ionic (electrostatic) interactions participate in the binding.
Kinetic Analysis of the Cellular Binding, Uptake, and Degradation of D3 Albumin
LECs in culture were used to assess the binding, uptake, and degradation of D3 albumin. The total binding of FITC-labeled D3 albumin to LECs increased up to the maximum dose (3 g/ml) we used. However, the specific binding, which can be calculated by subtracting the nonspecific binding from the total binding, showed a saturable curve (Fig. 4A) . Figure 4B shows the Scatchard plot of the specific binding, which gave parameters of K d ϭ 1.9 g/ml and B max ϭ 102.5 ng/mg of cell protein. We next examined the uptake of D3 albumin by LECs. The specific uptake of D3 albumin increased in a dose-dependent manner (Fig. 4C) and exhibited a maximal ligand uptake of 551 ng/mg of cell protein. Degradation of FITC-labeled D3 albumin estimated on the basis of the acid-soluble intensities of fluorescence increased similarly to the uptake (Fig. 4D) . Approximately one-fifth of the fluorescence was observed in the acid-soluble fraction compared with the uptake at the end of the 2-h incubation.
FITC-labeled F-Alb (but not D3 albumin) showed similar characteristics of binding, uptake, and degradation by LECs. FITC-labeled native albumin, however, showed negligible binding, uptake, and degradation compared with D3 albumin and F-Alb (data not shown).
Effects of Antibodies and Polyanionic Molecules on the Cellular Binding, Uptake, and Degradation of D3 Albumin
To evaluate the quantitative significance of gp18 and gp30 on the cellular binding, uptake, and degradation of D3 albumin, LECs were incubated with FITC-labeled D3 albumin and anti-gp18 IgG, anti-gp30 IgG, equimolar mixtures of gp18 and gp30 IgG, specific M-Alb IgG, and polyanionic molecules. A 10-fold molar excess of anti-gp18 IgG and anti-gp30 IgG reduced the binding of FITC-labeled D3 albumin to LECs to ϳ70% and ϳ60% of preimmune IgG, respectively (Fig. 5) . The equimolar mixture of the IgG showed an additive inhibitory effect on the binding, resulting in ϳ20% of the binding of the preimmune IgG. A 10-fold molar excess of specific M-Alb IgG reduced the binding to ϳ10% of preimmune IgG. Polyanionic molecules, the same as those described in Binding characteristics of D3 albumin to liver membrane proteins, and for concanavalin A, reduced the binding to 20 -70% of preimmune IgG, depending on the kinds of molecules (dextran sulfate and fucoidan are shown in Fig. 5 ). F-Alb and D3 albumin reduced the binding of FITC-labeled D3 albumin to LECs to ϳ10% of preimmune IgG. Native albumin did not significantly reduce the binding. Similar results were observed regarding the uptake of D3 albumin.
Further analyses of the IgG regarding the specific uptake and degradation of D3 albumin were performed using increasing concentrations of the IgG. An inhibitory effect of the anti-gp18 IgG on the uptake of D3 albumin reached a plateau value (70 -80% of the control) at a concentration of ϳ20 g/ml, and the effect did not change up to 100 g/ml (Fig. 6A) . The same Fig. 2 . Relationships between plasma levels of thiobarbituric acid-reactive substance (TBARS) and albumins. Total albumin (native ϩ denatured, E), D2 (OE), and D3 albumins (■) were quantified using native PAGE followed by Western blot analysis (see Table 1 and Fig. 1 ). Plasma TBARS levels were quantified using a fluorescence spectrophotometer (see Table 1 ). A-C: relationships for total, D2, and D3 albumins, respectively. but a slightly stronger inhibitory effect was observed when anti-gp30 IgG was used. The equimolar mixture of both antigp18 and anti-gp30 IgG showed additive inhibitory effects on the uptake of D3 albumin, resulting in ϳ20% of the control value at a concentration of 20 g/ml and up to 100 g/ml. The specific M-Alb IgG inhibited the uptake of D3 albumin most effectively, resulting in ϳ10% of the control at a concentration of 20 g/ml and up to 100 g/ml. Similar inhibitory effects of IgG were observed in the degradation of D3 albumin (Fig. 6B) . These results support the data shown in Figs. 3 and 5 and suggest that gp18 and gp30 are the main receptors for D3 albumin degradation in LECs.
Laser-scanning confocal microscopy was used to confirm the results obtained above. LECs were incubated with LysoTracker (a red fluorescent marker of the acidic lysosomal compartment) and Alexa 488-labeled D3 albumin for 2 h at 37°C. An overlay plot of these color distributions within the cell demonstrated that most of the D3 albumin existed in the lysosome (Fig. 7A) . The localization of cell surface gp18 and the binding site of D3 albumin were confirmed using an unsaturable dose (3 g/ml) of Cy3-labeled anti-gp18 IgG and Alexa 488-labeled D3 albumin. Again, these two colors coexisted on the cell surface (Fig. 7B) . Confocal images of Cy3-labeled anti-gp30 IgG were similar to those of Cy3-labeled anti-gp18 IgG (data not shown). A saturable dose (100 g/ml) of the equimolar mixture of anti-gp18 and anti-gp30 IgG completely blocked the D3 albumin binding (Fig. 7C) . Altogether, we confirmed that D3 albumin binds primarily to the cell surface proteins, gp18 and gp30, and is degraded in the lysosome of LECs.
Endocytic Pathways for D3 Albumin Degradation
We next attempted to elucidate the endocytic pathway of D3 albumin in LECs. For this purpose, we used two kinds of inhibitors: PAO (an inhibitor of clathrin-related endocytosis) as well as filipin and digitonin (inhibitors of caveolae-related endocytosis). PAO had no significant effects on the uptake and degradation of D3 albumin during the incubation for 2 h at 37°C. In contrast, both filipin and digitonin showed a strong inhibitory effect on the uptake and degradation of D3 albumin, resulting in reduced uptake and degradation to ϳ20% of the control (Fig. 8) . These results indicate that D3 albumin is degraded in the lysosome via caveolae-related endocytosis after binding to the cell surface receptors, gp18 and gp30. Confocal microscopic observations support the data shown in Fig. 8 . Intracellular D3 albumin (green in Fig. 9B ) coexisted with the lysosome in the presence of PAO, but no fluorescent signals derived from D3 albumin were observed in the presence of filipin (Fig. 9A) .
DISCUSSION
The major findings of the present study are as follows: 1) plasma concentrations of denatured (D2 and D3) albumin increase in response to oxidative stress, 2) D3 albumin binds to gp18 and gp30 membrane proteins prepared from rat liver, 3) gp18-and gp30-mediated endocytosis is the primary pathway for the degradation of D3 albumin in LECs, and 4) D3 albumin is incorporated into LECs by caveolae-related endocytosis and reaches the lysosome. We discuss these points in order below. 
Oxidative Stress and Plasma Concentrations of Denatured Albumins
We used five models of oxidative stress, including IHD, diabetes, acute inflammation, endotoxicosis, and aging. First, we determined the plasma levels of TBARS and total albumin in these five models to confirm whether the rats were under oxidative stress. As shown in Table 1 , we observed an increased level of TBARS in all models of oxidative stress used in this study, and these results are consistent with previous reports regarding IHD (10) , diabetes (30), inflammation (8) , and aging (24) . Meanwhile, total albumin decreased, which also has been reported previously for IHD (14) , diabetes (19) , acute inflammation (52), endotoxicosis (4), and aging (41) . In the present study, we observed a negative correlation between plasma TBARS and total albumin in the five models of oxidative stress, and the correlation coefficient was Ϫ0.94 through the models. These results suggest that the rats were under oxidative stress, although the severity of the oxidative stress differed within the models. We next determined the plasma concentrations of denatured (D2 and D3) albumin, both of which were previously isolated in rats with endotoxicosis (4), and found that levels of both D2 and D3 albumin increased significantly in the five models of oxidative stress (Figs. 1 and  2 ). Plasma levels of D3 albumin showed a positive correlation with that of TBARS (R ϭ 0.87). These results may indicate that free radical species attack plasma albumin and that the denatured albumins caused by the reaction are rapidly eliminated from the circulating blood, resulting in subsequently decreased concentrations of total albumin.
Plasma albumin is known to be a labile molecule against oxidative damage. It is thought to act as an antioxidant in the body to protect against oxidation of body components such as lowdensity lipoproteins (15) and bound fatty acids (42) . Kaski et al. (53) reported that IHD increases levels of ischemia modified albumin, which has no ability to bind cobalt. Era and colleagues have reported that diabetes (54) and aging (16) result in increased levels of oxidized albumin (nonmercaptalbumin). It is also known that albumin is denatured by free radicals in vitro (12). As described above, many kinds of modified and structurally altered albumins, including D2 and D3 albumins (4), have been reported. However, little is known about their degradative nature on a molecular basis. We therefore next attempted to characterize the degradative process of D3 albumin by using primary cultured rat liver endothelial cells.
D3 Albumin Binding to gp18 and gp30 Membrane Proteins
In previous studies by Schnitzer and colleagues (47, 51) , chemically denatured albumin such as F-Alb has been found to bind the 18-and 30-kDa proteins referred to as gp18 and gp30 from rat liver. In the present study, we attempted to confirm whether these membrane proteins equally recognize physiologically denatured albumin, D3 albumin. By using chemically modified albumins (F-Alb, M-Alb) and IgG against gp18 and gp30, the binding nature of D3 albumin to gp18 and gp30 was investigated using ligand blot analysis. A 10-fold molar excess of unlabeled D3 albumin significantly reduced the binding of FITC-labeled D3 albumin to gp18 and gp30 (Fig. 3, B and C) . The same effects were observed when FITC-labeled D3 albumin competed with F-and M-Alb, but not with native albumin. These results suggest that D3 albumin, F-Alb, and M-Alb expose the common binding sites to gp18 and gp30, which are hidden inside the molecule in the native state. This exposure may enable these three denatured albumins to compete with the binding to gp18 and gp30 membrane proteins.
Antibody against the specific epitopes of M-Alb as well as anti-gp18 and anti-gp30 IgG inhibited the D3 albumin binding to gp18 and gp30 membrane proteins to a similar degree (Fig.  3) . These findings indicate that the antibodies we prepared in this study specifically recognize the respective antigens and inhibit the binding of D3 albumin. The specific M-Alb IgG is thought to recognize D3 albumin's binding sites to gp18 and gp30 and/or to another site hidden inside the molecule in the native state.
Polyanionic molecules were used to characterize the binding between D3 albumin and gp18 or gp30. As shown in Fig. 3 , dextran sulfate and fucoidan significantly inhibited the binding, suggesting that ionic (electrostatic) interactions based on charged amino acids participate in the binding. The same inhibitory effects of polyanionic molecules have been observed in the binding between chemically modified albumin and gp18 or gp30 (47) as well as in the binding of the other scavenger receptors and their respective ligands (27, 28) . Many signal sequences such as PEST, KFERQ, YXRF, NPXY, COOH-terminal dileucine motif (LL), and so forth have been reported (6, 13) . The binding motif of albumin molecules to gp18 and gp30 receptors is of great interest with regard to albumin degradation, because this sequence could possibly recognize the albumin molecule to be broken down in the circulating blood. This sequence has not yet been elucidated, however, because the precise characteristics of gp18 and gp30, including their cDNA sequences, have not been investigated.
Binding, Uptake, and Degradation of D3 Albumin by LECs in Culture
Kinetic analysis of D3 albumin binding to LECs was performed (Fig. 4A) . A Scatchard plot of the specific binding (Fig.  4B ) revealed the following cell-protein parameters: K d ϭ 1.9 g/ml (28.6 nM) and B max ϭ 102.5 ng/mg. The binding affinity of D3 albumin to LECs is thought to be high compared with values reported previously in the literature; that is, the affinity between M-Alb and the microvascular endothelial cells from the epididymal fat pad (K d ϭ 48 nM) (47) and the affinity between modified albumin such as AGE-BSA and LOX-1 cells (K d ϭ 149 nM) (23) or AGE-BSA and CD36 (K d ϭ 62 nM) (34) . Such a high affinity between D3 albumin and LECs may contribute to the rapid elimination of denatured albumin from A: intracellular distributions of LysoTracker (a red fluorescent marker of the lysosomal compartment) and D3 albumin (green). The overlay plot (yellow) of these two colors indicates that D3 albumin existed in the lysosome within the LECs. B: cell surface distribution of gp18 and the binding sites of D3 albumin. Cy3-labeled anti-gp18 IgG (3 g/ml; red) and Alexa 488-labeled D3 albumin (green) were added to the medium and incubated for 2 h at 4°C. The same distribution patterns between gp18 and D3 albumin were observed on the cell surface. C: inhibitory effects of anti-gp18 and anti-gp30 IgG on the incorporation of D3 albumin into LECs. The same condition used in A was used, except for the addition of anti-gp18 and anti-gp30 IgG. The equimolar mixture of these IgG (100 g/ml) completely blocked the incorporation of D3 albumin. Each image is typical of three experiments in different cultures. Scale bar, 5 m. Fig. 8 . Effects of the endocytic inhibitors on the uptake and degradation of D3 albumin. LECs were incubated for 2 h at 37°C with FITC-labeled D3 albumin in the presence of phenylarsine oxide (PAO, an inhibitor of clathrin-related endocytosis), filipin, and digitonin (inhibitors of caveolae-related endocytosis). PAO (2 M) showed no effect on the uptake and degradation of D3 albumin. In contrast, both filipin (5 g/ml) and digitonin (4 M) inhibited the uptake and degradation of D3 albumin to ϳ20% of the control level. The specific uptake (closed bar) and degradation (open bar) were estimated in the same manner as described in Fig. 4 . Data are expressed as a percentage of the signal in the absence of any inhibitor (control). Statistical significance was evaluated using one-way ANOVA followed by Fisher's multiple range tests. ***P Ͻ 0.001 vs. control. circulating blood via the endothelial cell surface receptors gp18 and gp30.
The cellular binding and uptake of FITC-labeled D3 albumin were significantly inhibited by denatured albumins (D3 albumin, F-Alb, and M-Alb) and by antibodies (against gp18, gp30, and specific epitopes of M-Alb) (Fig. 5) . The same inhibitory results were observed in the ligand blot experiments (Fig. 3, B and C). The most remarkable observations regarding Figs. 5 and 6 are that anti-gp18 and gp30 IgG additively inhibited the binding and uptake of D3 albumin, resulting in an ϳ80% inhibition of the uptake and degradation of D3 albumin. These phenomena led us to think that gp18 and gp30 equally participate in the incorporation and degradation of D3 albumin and that most of the D3 albumin is incorporated into the cell by these receptors. The LECs degrade most of the modified albumin in the body (5) . Consequently, it may be that the degradation of D3 albumin via gp18 and gp30 is the primary degradation pathway in the body. In our experiments, gp18 and gp30 shared the ability to incorporate D3 albumin into the cell. This finding may be interpreted as follows. First, gp18 and gp30 may recognize the same binding site in denatured albumin. As such, gp18 and gp30 may contribute to the degradation of denatured albumin, depending on the number and affinity of each receptor exposed on the cell surface. Second, gp18 and gp30 may recognize different sites of denatured albumin. Each receptor in this case may correspond to degraded, denatured albumin with different steric conformations resulting from various changes in body status. In any case, precise experiments are needed concerning the amino acid sequences that bind to gp18 and gp30.
Incorporation of D3 Albumin by Caveolae-Related Endocytosis
The mechanisms underlying receptor-mediated endocytosis are thought to be divided into two categories based on the proteins that participate in the endocytic process: clathrinrelated endocytosis and caveolae-related endocytosis (45) . We used the specific inhibitors of these endocytic processes to confirm the process used in the degradation of D3 albumin. As shown in Fig. 8 , both filipin and digitonin, specific inhibitors of caveolae-related endocytosis, inhibited the uptake and degradation of D3 albumin in LECs in culture. In contrast, PAO, an inhibitor of clathrin-related endocytosis, showed no significant effect on the uptake and degradation of D3 albumin. This evidence strongly suggests that D3 albumin travels with caveolae to the lysosome after attaching to the cell surface receptors gp18 and gp30. Confocal microscopic observations support the above hypothesis (Fig. 9) . To date, the caveolin molecule has been revealed to participate in cellular trafficking of modified albumins in endothelial cells (46, 50) . However, a recent report by Hansen et al. (20) indicated that endothelial cells incorporate the modified albumin using clathrin rather than caveolin vesicles. The reason for this different pathway is thought to be the difference in the albumin molecules. Intracellular transport of albumin molecules seems to take different pathways, depending on the receptors that can recognize the structural and modificational nature of the albumin molecule, and this difference is partly defined as follows. Complexes with native albumin and gp60 (albondin) (32, 46, 57) and complexes with gold-albumin and gp18 and/or gp30 (46, 50) are internalized via caveolae-related endocytosis, whereas complexes of AGEalbumin and stabilin-2 (FEEL-2) are internalized via clathrinrelated endocytosis (20) . No data are available, however, to elucidate the cellular events occurring after albumin attaches to gp18 and gp30. In the present study, we have obtained direct evidence that physiologically denatured albumin is degraded via caveolae-mediated endocytosis after attaching to the cell surface receptors gp18 and gp30.
In summary, we first demonstrated that oxidative stress generally increases levels of denatured albumin (D2 and D3 albumin) in circulating blood in rats. Second, we have shown that D3 albumin binds to the 18-and 30-kDa membrane proteins that have been reported as scavenger receptors named gp18 and gp30 for chemically modified albumin. Third, we have demonstrated that gp18-and gp30-mediated endocytosis is the primary pathway for the degradation of denatured albumin in primary cultured endothelial cells. Fourth, we have obtained direct evidence that caveolae-mediated endocytosis is the route for the degradation of physiologically denatured albumin after attaching to the cell-surface receptors gp18 and gp30. On the basis of these results and our previous findings, we think that we can provide a sequencing image for the degradation of serum albumin, taking into account both the generation of denatured albumin in vivo and the recognition of denatured albumin on the cell surface and intracellular events for the degradation of denatured albumin. At present, however, we have no information available that would allow us to answer the following questions. 1) Is there a receptor that can recognize native albumin and lead to its degradation? 2) Are there amino acid sequences in albumin molecules that can be recognized by gp18 and gp30? 3) What is the production rate of denatured albumin in vivo? On the basis of our present findings, we may be able to elucidate more precisely the details of the degradative process, particularly in the setting of oxidative stress.
